Cargando…

Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases

Ferroptosis is a novel type of regulated cell death driven by iron-dependent lipid peroxidation, which is distinguished from traditional types of programmed cell death, such as apoptosis, proptosis and necrosis et al. Impaired iron homeostasis, lipid peroxidation and antioxidants depletion are three...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyue, Wei, Yanchen, Wei, Fangyi, Kuang, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098117/
https://www.ncbi.nlm.nih.gov/pubmed/37065851
http://dx.doi.org/10.3389/fcell.2023.1146971
_version_ 1785024730601881600
author Wang, Xinyue
Wei, Yanchen
Wei, Fangyi
Kuang, Haibin
author_facet Wang, Xinyue
Wei, Yanchen
Wei, Fangyi
Kuang, Haibin
author_sort Wang, Xinyue
collection PubMed
description Ferroptosis is a novel type of regulated cell death driven by iron-dependent lipid peroxidation, which is distinguished from traditional types of programmed cell death, such as apoptosis, proptosis and necrosis et al. Impaired iron homeostasis, lipid peroxidation and antioxidants depletion are three hallmarks of ferroptosis. Over the past years, emerging studies support the notion that ferroptosis might be involved in the pathology of obstetrical and gynecological diseases, including preeclampsia (PE), endometriosis (EMs) and polycystic ovarian syndrome (PCOS). In the PE condition, the high sensitivity of trophoblasts towards ferroptosis has been found to potentially link to inflammation, suboptimal vascular remodeling and aberrant hemodynamics, which are three prominent pathophysiological features of PE. As for EMs, compromised ferroptosis of endometrial cells was associated with the formation ectopic lesions, whereas in the nearby lesions, the presence of ferroptosis was suggested to promote the progression of EMs, contributing to the relative clinical manifestations. Ferroptosis has been implicated a crucial role in the initiation of ovarian follicular atresia, which might help to manage ovulation in PCOS patients. Taken together, this review explored the basis of ferroptosis mechanisms and comprehensively summarized the latest discovery of roles of ferroptosis on PE, EMs and PCOS, gaining a deeper insight into the pathogenesis of these obstetrical and gynecological diseases and investigation of novel therapeutic interventions.
format Online
Article
Text
id pubmed-10098117
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100981172023-04-14 Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases Wang, Xinyue Wei, Yanchen Wei, Fangyi Kuang, Haibin Front Cell Dev Biol Cell and Developmental Biology Ferroptosis is a novel type of regulated cell death driven by iron-dependent lipid peroxidation, which is distinguished from traditional types of programmed cell death, such as apoptosis, proptosis and necrosis et al. Impaired iron homeostasis, lipid peroxidation and antioxidants depletion are three hallmarks of ferroptosis. Over the past years, emerging studies support the notion that ferroptosis might be involved in the pathology of obstetrical and gynecological diseases, including preeclampsia (PE), endometriosis (EMs) and polycystic ovarian syndrome (PCOS). In the PE condition, the high sensitivity of trophoblasts towards ferroptosis has been found to potentially link to inflammation, suboptimal vascular remodeling and aberrant hemodynamics, which are three prominent pathophysiological features of PE. As for EMs, compromised ferroptosis of endometrial cells was associated with the formation ectopic lesions, whereas in the nearby lesions, the presence of ferroptosis was suggested to promote the progression of EMs, contributing to the relative clinical manifestations. Ferroptosis has been implicated a crucial role in the initiation of ovarian follicular atresia, which might help to manage ovulation in PCOS patients. Taken together, this review explored the basis of ferroptosis mechanisms and comprehensively summarized the latest discovery of roles of ferroptosis on PE, EMs and PCOS, gaining a deeper insight into the pathogenesis of these obstetrical and gynecological diseases and investigation of novel therapeutic interventions. Frontiers Media S.A. 2023-03-30 /pmc/articles/PMC10098117/ /pubmed/37065851 http://dx.doi.org/10.3389/fcell.2023.1146971 Text en Copyright © 2023 Wang, Wei, Wei and Kuang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Wang, Xinyue
Wei, Yanchen
Wei, Fangyi
Kuang, Haibin
Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title_full Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title_fullStr Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title_full_unstemmed Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title_short Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
title_sort regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098117/
https://www.ncbi.nlm.nih.gov/pubmed/37065851
http://dx.doi.org/10.3389/fcell.2023.1146971
work_keys_str_mv AT wangxinyue regulatorymechanismandresearchprogressofferroptosisinobstetricalandgynecologicaldiseases
AT weiyanchen regulatorymechanismandresearchprogressofferroptosisinobstetricalandgynecologicaldiseases
AT weifangyi regulatorymechanismandresearchprogressofferroptosisinobstetricalandgynecologicaldiseases
AT kuanghaibin regulatorymechanismandresearchprogressofferroptosisinobstetricalandgynecologicaldiseases